Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Guilin Sanjin Pharma Will Be First China IPO of 2009

publication date: Jun 19, 2009
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Guilin Sanjin Pharmaceutical Co., a maker of traditional Chinese medicines, will be the first China IPO of any sector in 2009. The company is planning to make its debut on June 29 on the Shenzhen exchange. China regulators banned IPOs nine months ago, after the Shanghai Composite Index fell 60% in 2008. Guilin Sanjin will issue up to 46 million new shares to fund 10 projects that will require 634 million RMB ($93 million) of investment. More details...

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...